Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05186415 · ClinicalTrials.gov registry record · Phase 1
Contrast Enhanced 3D Echocardiographic Quantification of Right Ventricular Volumes in Repaired CHD
A Phase 1 study of Tetralogy of Fallot and Pulmonary Insufficiency, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05186415 is a Phase 1 study of Tetralogy of Fallot and Pulmonary Insufficiency that has completed, run by Nemours Children's Clinic. The registered enrollment target is 25 participants, below the 186-participant average among 7 other Tetralogy of Fallot trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05186415, a Phase 1 study of Tetralogy of Fallot and Pulmonary Insufficiency, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
We propose the novel integration of two echocardiographic technologies - three-dimensional echocardiography using semi-automated right ventricular analysis coupled with the administration of ultrasound enhancing agents - to improve the inter-rater reliability and accuracy of various measures of right ventricular size and function, compared with cardiac MRI.
Conditions Studied
Interventions
- DRUG Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]
Study Locations (1)
Delaware
- Nemours Childrens Hospital - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-08-23 |
| Est. Completion | 2024-06-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05186415
The ClinicalTrials.gov registry entry for NCT05186415 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 186-participant average among 7 other Tetralogy of Fallot trials with a reported enrollment target (87% lower). The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tetralogy of Fallot appearing as the primary indexed condition, and to 1 intervention - of which Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] is the first listed.
NCT05186415 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.
Frequently Asked Questions
What is clinical trial NCT05186415 about?
NCT05186415 is a clinical study titled "Contrast Enhanced 3D Echocardiographic Quantification of Right Ventricular Volumes in Repaired CHD". We propose the novel integration of two echocardiographic technologies - three-dimensional echocardiography using semi-automated right ventricular analysis coupled with the administration of ultrasound enhancing agents - to improve the inter-rater reliability and accuracy of various measures of righ...
What is the current status of trial NCT05186415?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2022-08-23. Estimated completion is 2024-06-25.
What conditions does trial NCT05186415 study?
This clinical trial studies the following conditions: Tetralogy of Fallot, Pulmonary Insufficiency.
What interventions are being tested in trial NCT05186415?
The interventions under investigation include: Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] (DRUG).
Who is sponsoring clinical trial NCT05186415?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05186415 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tetralogy of Fallot
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Beta-blocker Administration for Cardiomyocyte Division
RECRUITING · Phase 1
-
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
RECRUITING
-
Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
RECRUITING
-
ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent
ACTIVE NOT RECRUITING · NA
-
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
ACTIVE NOT RECRUITING · NA
-
ALTERRA Post-Approval Study
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.